However, a Cx47 knockout mouse did not display any clinical symptoms (Odermatt et al., 2003), which hints that Cx47 mutations in PMLD patients may exert a toxic gain-of-function effect. This evidence concerns the gene GJC2 and Pelizaeus-Merzbacher-like disease.